Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Compound pharmaceutical composition using glucosamine and sodium chondroitin sulfate as main medicaments

A technology of sodium chondroitin sulfate and glucosamine, which can be used in drug combinations, pharmaceutical formulations, antipyretics, etc., can solve problems such as large side effects and poor therapeutic effects, and achieve the effects of accelerated repair and excellent curative effect.

Inactive Publication Date: 2013-06-19
黑龙江迪龙制药有限公司
View PDF3 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] The purpose of the present invention is to solve the problem of poor curative effect and large side effects of existing drugs for treating arthritis, and provides a compound pharmaceutical composition with glucosamine and sodium chondroitin sulfate as main agents

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Compound pharmaceutical composition using glucosamine and sodium chondroitin sulfate as main medicaments
  • Compound pharmaceutical composition using glucosamine and sodium chondroitin sulfate as main medicaments
  • Compound pharmaceutical composition using glucosamine and sodium chondroitin sulfate as main medicaments

Examples

Experimental program
Comparison scheme
Effect test

specific Embodiment approach 1

[0010] Specific embodiment one: a kind of compound pharmaceutical composition with glucosamine and chondroitin sulfate sodium as the main ingredients in this embodiment, including glucosamine, chondroitin sulfate sodium and auxiliary materials; wherein, the glucosamine and chondroitin sulfate The mass ratio of sodium is 4-6:4, the mass ratio of glucosamine to auxiliary materials is 140-160:77, and the glucosamine is glucosamine sulfate or glucosamine hydrochloride.

[0011] In this embodiment, chondroitin sulfate and glucosamine are compatible with each other to form a compound pharmaceutical composition for treating bone and joint diseases. The combined prescription of glucosamine and chondroitin sulfate is used for the treatment of bone and joint diseases. It can effectively anti-inflammation, but also accelerate the repair of bone and articular cartilage, promote the synthesis of cartilage matrix and reduce the degradation and destruction of cartilage, and its curative effec...

specific Embodiment approach 2

[0012] Embodiment 2: This embodiment differs from Embodiment 1 in that: the mass ratio of glucosamine to excipients is 145-155:77. Others are the same as in the first embodiment.

specific Embodiment approach 3

[0013] Embodiment 3: This embodiment differs from Embodiment 1 or Embodiment 2 in that: the mass ratio of glucosamine to auxiliary materials is 150:77. Others are the same as in the first or second embodiment.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a compound pharmaceutical composition using glucosamine and sodium chondroitin sulfate as main medicaments, and relates to a compound pharmaceutical composition. The compound pharmaceutical composition solves the problems the conventional medicament for treating arthritis has poor treatment effect and large side effect. The compound pharmaceutical composition comprises the glucosamine, the sodium chondroitin sulfate and accessories, wherein the mass ratio of the glucosamine to the sodium chondroitin sulfate is (4-6): 4, the mass ratio of the glucosamine to the accessories is (140-160): 77, and the glucosamine is glucosamine sulfate or glucosamine hydrochloride. The glucosamine and the sodium chondroitin sulfate are synergistic for treating arthropathy, so that inflammation can be effectively resisted, repair of articular cartilages can be accelerated, synthesis of cartilage matrix is promoted, and degradation and destroy of the cartilages are reduced. The composition is applied to the field of arthritis treatment.

Description

technical field [0001] The invention relates to a compound pharmaceutical composition. Background technique [0002] Chronic joint inflammation such as rheumatoid arthritis and rheumatoid arthritis can lead to damage and degeneration of articular cartilage, and joint sports injuries and other injuries can also cause cartilage damage. Therefore, in the treatment of bone and joint diseases, On the one hand, control and eliminate the development of inflammation, on the other hand, strengthen the repair of articular cartilage, so as to restore the normal physiological functions of the joints. At present, in my country, among the middle-aged and elderly people, people suffering from rheumatic and rheumatoid arthritis joint diseases The proportion is very high. According to a statistics from the health department, more than 80% of the elderly over the age of 60 suffer from different degrees of bone and joint diseases, which has become an equally important disease affecting the healt...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/737A61K31/7008A61P19/02A61P29/00A61P19/08
Inventor 董继胜王金富冯文善魏彦赵波
Owner 黑龙江迪龙制药有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com